2-amino-5-phosphonovalerate has been researched along with Lung Diseases in 1 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
Lung Diseases: Pathological processes involving any part of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Said, SI | 1 |
| Berisha, HI | 1 |
| Pakbaz, H | 1 |
1 other study available for 2-amino-5-phosphonovalerate and Lung Diseases
| Article | Year |
|---|---|
N-methyl-D-aspartate receptors outside the central nervous system: activation causes acute lung injury that is mediated by nitric oxide synthesis and prevented by vasoactive intestinal peptide.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cyclic GMP; Lung Diseases; N-Methylaspartate; Nitric Oxide; Or | 1995 |